MDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53

被引:1
|
作者
Klein, Alyssa M. [1 ,2 ]
Biderman, Lynn [1 ]
Tong, David [1 ]
Alaghebandan, Bita [1 ]
Plumber, Sakina A. [1 ]
Mueller, Helen S. [1 ]
van Vlimmeren, Anne [1 ]
Katz, Chen [1 ]
Prives, Carol [1 ]
机构
[1] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA
[2] Columbia Univ, Integrated Program Cellular Mol & Biomed Studies, New York, NY 10032 USA
关键词
cell cycle; MDM2; MDMX; p73; RING-FINGER DOMAIN; EMBRYONIC LETHALITY; MUTANT P53; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL TURNOVER; MDM2-DEFICIENT MICE; P53-HOMOLOG P73; E2F FAMILY; CANCER; PROTEIN;
D O I
10.1073/pnas.2102420118j1of10
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The p53 tumor suppressor protein, known to be critically important in several processes including cell-cycle arrest and apoptosis, is highly regulated by multiple mechanisms, most certifiably the Murine Double Minute 2-Murine Double Minute X (MDM2-MDMX) heterodimer. The role of MDM2-MDMX in cell-cycle regulation through inhibition of p53 has been well established. Here we report that in cells either lacking p53 or expressing certain tumorderived mutant forms of p53, loss of endogenous MDM2 or MDMX, or inhibition of E3 ligase activity of the heterocomplex, causes cell-cycle arrest. This arrest is correlated with a reduction in E2F1, E2F3, and p73 levels. Remarkably, direct ablation of endogenous p73 produces a similar effect on the cell cycle and the expression of certain E2F family members at both protein and messenger RNA levels. These data suggest that MDM2 and MDMX, working at least in part as a heterocomplex, may play a p53-independent role in maintaining cell-cycle progression by promoting the activity of E2F family members as well as p73, making them a potential target of interest in cancers lacking wild-type p53.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Mdm2 and MdmX partner to regulate p53
    Wang, Xinjiang
    Jiang, Xuejun
    [J]. FEBS LETTERS, 2012, 586 (10) : 1390 - 1396
  • [2] Interaction of regulators Mdm2 and Mdmx with transcription factors p53, p63 and p73
    Zdzalik, Michal
    Pustelny, Katarzyna
    Kedracka-Krok, Sylwia
    Huben, Krzysztof
    Pecak, Aleksandra
    Wladyka, Benedykt
    Jankowski, Stefan
    Dubin, Adam
    Potempa, Jan
    Dubin, Grzegorz
    [J]. CELL CYCLE, 2010, 9 (22) : 4584 - 4591
  • [3] The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors
    Spiegelberg, Diana
    Mortensen, Anja C.
    Lundsten, Sara
    Brown, Christopher J.
    Lane, David P.
    Nestor, Marika
    [J]. CANCER RESEARCH, 2018, 78 (17) : 5084 - 5093
  • [4] MDM2 and MDMX bind and stabilize the p53-related protein p73
    Ongkeko, WM
    Wang, XQ
    Siu, WY
    Lau, AWS
    Yamashita, K
    Harris, AL
    Cox, LS
    Poon, RYC
    [J]. CURRENT BIOLOGY, 1999, 9 (15) : 829 - 832
  • [5] Wild-type p53 and p73 negatively regulate expression of proliferation related genes
    Scian, M. J.
    Carchman, E. H.
    Mohanraj, L.
    Stagliano, K. E. R.
    Anderson, M. A. E.
    Deb, D.
    Crane, B. M.
    Kiyono, T.
    Windle, B.
    Deb, S. P.
    Deb, S.
    [J]. ONCOGENE, 2008, 27 (18) : 2583 - 2593
  • [6] Wild-type p53 and p73 negatively regulate expression of proliferation related genes
    M J Scian
    E H Carchman
    L Mohanraj
    K E R Stagliano
    M A E Anderson
    D Deb
    B M Crane
    T Kiyono
    B Windle
    S P Deb
    S Deb
    [J]. Oncogene, 2008, 27 : 2583 - 2593
  • [7] Subcellular distribution of p53 and p73 are differentially regulated by MDM2
    Gu, JJ
    Nie, LH
    Kawai, H
    Yuan, ZM
    [J]. CANCER RESEARCH, 2001, 61 (18) : 6703 - 6707
  • [8] Mdm2 and MdmX: Partners in p53 Destruction
    Manfredi, James J.
    [J]. CANCER RESEARCH, 2021, 81 (07) : 1633 - 1634
  • [9] Profiling inhibitors of MDM2: p53 and MDMX: p53 in relation to MDMX protein levels
    Tudhope, Sue
    Zhao, Yan
    Wittner, Anita
    Wilmore, Elaine
    Bertoli, Annalisa
    Adhikari, Santosh
    Harnor, Suzannah J.
    Del Bello, Fabio
    Piergentili, Alessandro
    Lunec, John
    Hardcastle, Ian R.
    Griffin, Roger J.
    Golding, Bernard R.
    Cano, Celine
    Newell, David R.
    Wedge, Stephen R.
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [10] A possible role of p73 on the modulation of p53 level through MDM2
    Wang, XQ
    Ongkeko, WM
    Lau, AWS
    Leung, KM
    Poon, RYC
    [J]. CANCER RESEARCH, 2001, 61 (04) : 1598 - 1603